Tamoxifen reduces serum insulin-like growth factor I (IGF-I)

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Breast Cancer Research and Treatment

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF01833337PMID 1421427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CHARACTERIZATION OF INSULIN-LIKE GROWTH FACTOR I (IGF-I) RECEPTORS OF HUMAN BREAST CANCER CELLS

  2003cited by this paper
• Insulin-like Growth Factors and Cancer

  1995cited by this paper
• Direct effects of tamoxifen on growth hormone secretion by pituitary cells in vitro.

  1992cited by this paper
• Pancreatic carcinoma.

  1992cited by this paper
• Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients.

  1992cited by this paper
• Inhibition of metastatic behavior of murine osteosarcoma by hypophysectomy.

  1992cited by this paper
• Insulin-like growth factors and cancer.

  1992cited by this paper
• Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin.

  1992cited by this paper
• Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors.

  1992cited by this paper
• Short-term adult exposure to estradiol feminizes the male pattern of spontaneous and growth hormone-releasing factor-stimulated growth hormone secretion in the rat.

  1992cited by this paper
• Growth hormone therapy in elderly people

  1991cited by this paper
• Paracrine actions of IGF binding proteins.

  1991cited by this paper
• Estrogen induction of growth hormone in the thyroidectomized rat.

  1991cited by this paper
• Therapeutic Implications of Recent Growth Factor Research

  1991cited by this paper
• Growth hormone therapy in elderly people.

  1991cited by this paper
• Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment.

  1991cited by this paper
• Insulinlike growth factor I: a potent mitogen for human osteogenic sarcoma.

  1990cited by this paper
• Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells.

  1990cited by this paper
• Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity.

  1990cited by this paper
• Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer.

  1990cited by this paper
• Insulin-like growth factors and their binding proteins.

  1990cited by this paper
• Growth hormone-releasing hormone messenger ribonucleic acid in the hypothalamus of the adult male rat is increased by testosterone.

  1990cited by this paper
• Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture.

  1990cited by this paper
• Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients.

  1990cited by this paper
• Effects of human growth hormone in men over 60 years old.

  1990cited by this paper
• Effect of fasting on insulin-like growth factor-I (IGF-I) and growth hormone receptor mRNA levels and IGF-I gene transcription in rat liver.

  1990cited by this paper
• Evidence for direct action of estradiol on growth hormone-releasing factor (GRF) in rat hypothalamus: localization of [3H]estradiol in GRF neurons.

  1990cited by this paper
• Effects of human growth hormone in men over 60 years old.

  1990cited by this paper
• Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

  1990cited by this paper
• Comparison of insulin-like growth factor 1 and insulin effects on prolactin-induced lactogenesis in the rabbit mammary gland in vitro.

  1989cited by this paper
• A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.

  1989cited by this paper
• Specificity spillover at the hormone receptor--exploring its role in human disease.

  1989cited by this paper
• Impact of Human Growth Hormone on Plasma Lipoprotein Concentrations

  1989cited by this paper
• Sexual dimorphism and testosterone-dependent regulation of somatostatin gene expression in the periventricular nucleus of the rat brain.

  1989cited by this paper
• Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer.

  1989cited by this paper
• Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.

  1989cited by this paper
• Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I.

  1989cited by this paper
• Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer.

  1989cited by this paper
• Estrogen Stimulates both Prolactin and Growth Hormone mRNAs Expression in the MtT/F4 Transplantable Pituitary Tumor

  1989cited by this paper
• Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

  1989cited by this paper
• Growth factor binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors from rats subject to chronic caloric restriction.

  1989cited by this paper
• Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer.

  1989cited by this paper
• The effects of estrogens on tumor growth and on prolactin and growth hormone mRNA expression in rat pituitary tissues.

  1988cited by this paper
• Steroid regulation of somatostatin mRNA in the rat hypothalamus.

  1988cited by this paper
• Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines.

  1988cited by this paper
• In vitro regulation of growth hormone (GH) release from ovine pituitary cells during fetal and neonatal development: effects of GH-releasing factor, somatostatin, and insulin-like growth factor I.

  1988cited by this paper
• Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors.

  1988cited by this paper
• Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat.

  1988cited by this paper
• Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer.

  1988cited by this paper
• Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cells.

  1988cited by this paper
• Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance.

  1988cited by this paper
• Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells.

  1987cited by this paper
• An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture.

  1987cited by this paper
• Effect of estrogen on the growth hormone (GH) secretory response to GH-releasing factor in the castrate adult female rat in vivo.

  1987cited by this paper
• Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations.

  1987cited by this paper
• Inhibitory effect of the ovaries on neonatal androgen imprinting of growth hormone secretion in female rats.

  1987cited by this paper
• Response of multicentric desmoid tumours to tamoxifen

  1987cited by this paper
• Presence of somatomedin receptors on primary human breast and colon carcinomas.

  1987cited by this paper
• Growth hormone regulates the abundance of insulin-like growth factor I RNA in adult rat liver.

  1986cited by this paper
• Stimulation of growth hormone release and synthesis by estrogens in rat anterior pituitary cells in culture.

  1986cited by this paper
• Regulation of insulin-like growth factor I gene expression by growth hormone.

  1986cited by this paper
• Sexual dimorphism in the control of growth hormone secretion.

  1985cited by this paper
• Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system. An immunohistochemical study.

  1985cited by this paper
• Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone.

  1985cited by this paper
• Somatomedin-C levels in children and adolescents with gonadal dysgenesis: differences from age-matched normal females and effect of chronic estrogen replacement therapy.

  1985cited by this paper
• Multiple hormones stimulate the production of somatomedin by cultured human fibroblasts.

  1984cited by this paper
• Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture.

  1984cited by this paper
• Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action.

  1984cited by this paper
• The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion.

  1984cited by this paper
• Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status.

  1983cited by this paper
• Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts.

  1981cited by this paper
• Release of somatomedin-like activity by cultured WI-38 human fibroblasts.

  1980cited by this paper
• Evidence that somatomedin is synthesized by multiple tissues in the fetus.

  1980cited by this paper
• Effect of hypophysectomy and hormone replacement of hormone receptor levels and the growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.

  1980cited by this paper
• The brain as a target for steroid hormone action.

  1979cited by this paper
• Plasma somatomedin and growth hormone values in children with protein-calorie malnutrition.

  1978cited by this paper
• A study of diet and breast cancer.

  1978cited by this paper
• Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women.

  1976cited by this paper
• Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata.

  1976cited by this paper
• Hormone responsive human breast cancer in long-term tissue culture: effect of insulin.

  1976cited by this paper
• Bromocriptine in the treatment of advanced breast cancer.

  1976cited by this paper
• Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man.

  1976cited by this paper
• Inhibition of oestrogen-stimulated prolactin release by anti-oestrogens.

  1975cited by this paper
• Pituitary role in the estrogen dependency of experimental mammary cancer.

  1963cited by this paper
• Hypophysectomy in treatment of disseminated breast cancer.

  1962cited by this paper

• Modelling anti-estrogen resistance in estrogen receptor-positive breast cancer: molecular mechanisms and emerging therapeutic strategies

  2025cites this paper
• The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations

  2023cites this paper
• The expression level of mir‐21‐3p in platelet‐rich plasma: A potential effective factor and predictive biomarker in recurrent implantation failure

  2022cites this paper
• Nutritional Status Predicts Fatty Acid Uptake from Fish and Soybean Oil Supplements for Treatment of Cancer-Related Fatigue: Results from a Phase II Nationwide Study

  2021cites this paper
• Quality of life in Hungarian polio survivors

  2021cites this paper
• The significance of estrogen receptors in acromegaly: Are they useful as predictors of prognosis and therapy regimen?

  2020cites this paper
• The effect of tamoxifen on IGF signaling pathway in mouse ovary

  2019cites this paper
• Anticancer potential of nutraceutical formulation through antioxidant, anti-inflammatory, and antiproliferative mechanisms in N-methyl-N-nitrosourea-induced mammary cancer

  2018cites this paper
• Qualitative Versus Quantitative Mammographic Breast Density Assessment: Applications for the US and Abroad

  2017cites this paper
• Studies on the pathophysiology of bile acid-induced inflammatory airways disease

  2017cites this paper
• Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies

  2016cites this paper
• Estrogens and selective estrogen receptor modulators in acromegaly

  2016cites this paper
• Prepubertal tamoxifen treatment affects development of heifer reproductive tissues and related signaling pathways.

  2016cites this paper
• Tamoxifen Prevents Apoptosis and Follicle Loss from Cyclophosphamide in Cultured Rat Ovaries1

  2015cites this paper
• There is overwhelming evidence that alterations in endogenous hormone metabolism - as a form of endogenous exposure—may bean important metabolic riskfactorfor the development of breast cancer. This chapter reviews current theories and major epidemiological findings that link endogenous hormones (sex

  2014cites this paper
• Insights into the protective mechanisms of tamoxifen in radiotherapy-induced ovarian follicular loss: impact on insulin-like growth factor 1.

  2013cites this paper
• Associations of insulin‐like growth factor and insulin‐like growth factor binding protein‐3 with mortality in women with breast cancer

  2013cites this paper
• Expression and inhibition of ADAMDEC1 in craniopharyngioma cells

  2012cites this paper
• Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses’ Health Studies

  2012cites this paper
• Hormonal mechanisms underlying the relationship between obesity and breast cancer.

  2011cites this paper
• Dietary Intervention of Flaxseed: Effect on Serum Levels of IGF-1, IGF-BP3, and C-Peptide

  2011cites this paper
• Phenotypic characterization and differentiation potential of cells from human placenta: new approaches of stem cell theraphy for cystic fibrosis

  2011cites this paper
• PCOS and cancer risk.

  2010cites this paper
• Surrogate response biomarkers in prevention research: do they point the way or lead us astray?

  2009cites this paper
• Estrogen receptor-mediated effects in the gonadotropic L T2 and T3-1 cell lines

  2008cites this paper
• IGF Binding Proteins (IGFBPs) and Regulation of Breast Cancer Biology

  2008cites this paper
• GENETIC VARIATION AT THE INSULIN-LIKE GROWTH FACTOR 1 GENE AND ASSOCIATION WITH BREAST CANCER, BREAST DENSITY AND ANTHROPOMETRIC MEASURES

  2008cites this paper
• Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.

  2007cites this paper
• Die Effekte von Tamoxifen auf die Knochendichte und das Frakturrisiko

  2007cites this paper
• Use of biomarkers for breast cancer risk assessment and prevention.

  2007cites this paper
• Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study

  2007cites this paper
• Advances in Brief In Vivo Inhibition of Insulin-like Growth Factor I Gene Expression by Tamoxifen 1

  2006cites this paper
• Insulin-like growth factor-I (IGF-I) and IGF-binding proteins blood serum levels in women with early- and late-stage breast cancer: mutual relationship and possible correlations with patients' hormonal status

  2005cites this paper
• 17beta-estradiol regulation of human growth hormone (hGH), insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) axis in hypoestrogenic, hypergonadotropic women.

  2005cites this paper
• Insulin-Like Growth Factor Binding Proteins (IGFBPs) in Breast Cancer

  2004cites this paper
• IGF-I in mammary tumorigenesis and diabetes.

  2004cites this paper
• Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer

  2004cites this paper
• Effect of two 4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer

  2004cites this paper
• Alternative mechanisms of action of anti-oestrogens

  2004cites this paper
• Tamoxifen Alters Hepatic Cytochrome P450 Enzyme Expression and Circulating Growth Hormone Levels in Intact Male Rats

  2004cites this paper
• Antiestrogens – Tamoxifen, SERMs and Beyond

  2004cites this paper
• 23 – Phytoestrogens and the prevention of cancer

  2004cites this paper
• Klinische Wertigkeit der Wachstumsfaktoren Vascular Endothelial Growth Factor (VEGF) und Insulin-like Growth Factor-1 (IGF-1) und des Bindungsproteins IGFBP-3 bei der Untersuchung von Frauen mit erhöhtem Brustkrebsrisiko

  2003cites this paper
• The Insulin-Like Growth Factor (IGF) Family and Breast Cancer

  2003cites this paper
• IGFBPs and Breast Cancer

  2003cites this paper
• Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells.

  2003cites this paper
• Breast cancer chemoprevention: current challenges and a look toward the future.

  2002cites this paper
• Mammalian phytoestrogens: enterodiol and enterolactone.

  2002cites this paper
• Treatment of Metastatic Osteosarcoma With the Somatostatin Analog OncoLar: Significant Reduction of Insulin-Like Growth Factor-1 Serum Levels

  2002cites this paper
• The relationship between serum GH and serum IGF-I in acromegaly is gender-specific.

  2001cites this paper
• Induction of UO-44 gene expression by tamoxifen in the rat uterus and ovary.

  2001cites this paper
• Inhibitory action on GHRH‐induced GH secretion of chronic tamoxifen treatment in breast cancer

  2000cites this paper
• The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.

  2000cites this paper
• Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside.

  2000cites this paper
• Growth hormone receptor antagonists therapy for acromegaly.

  1999cites this paper
• p53 down-regulates ER-responsive genes by interfering with the binding of ER to ERE.

  1999cites this paper
• Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.

  1999cites this paper
• Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma.

  1998cites this paper
• Igf system components as prognostic markers in breast cancer

  1998cites this paper
• An experimental model of diabetes and cancer in rats.

  1998cites this paper
• Mechanisms of action of antiestrogens: relevance to clinical benefits and risks.

  1998cites this paper
• Comparison of tamoxifen effects on the actions of triiodothyronine or growth hormone in the ovariectomized-hypothyroid rat.

  1998cites this paper
• Basic guide to the mechanisms of antiestrogen action.

  1998cites this paper
• Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes.

  1998cites this paper
• Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer.

  1998cites this paper
• Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors

  1998cites this paper
• Igf-independent regulation of breast cancer growth by IGF binding proteins

  1998cites this paper
• Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.

  1997cites this paper
• Perspectives in cancer chemoprevention.

  1997cites this paper
• Tamoxifen attenuates glucocorticoid actions on bone formation in vitro.

  1997cites this paper
• Anti-proliferative effect of toremifene and tamoxifen on estrogen receptor-lacking anaplastic thyroid carcinoma cell lines.

  1997cites this paper
• Effects of aromatase complex selective inhibition on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 circulating levels in breast cancer.

  1997cites this paper
• Long‐term inhibitory effects of a novel anti‐estrogen on the growth of ZR‐75‐1 and MCF‐7 human breast cancer tumors in nude mice

  1997cites this paper
• Effects of estrogen and tamoxifen on the MAP kinase cascade in experimental rat breast cancer.

  1997cites this paper
• Dairy products and breast cancer: the IGF-I, estrogen, and bGH hypothesis.

  1997cites this paper
• Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells.

  1997cites this paper
• Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.

  1997cites this paper
• Hormone dependence of mammary tumors induced in rats by intraperitoneal NMU injection.

  1997cites this paper
• Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat.

  1997cites this paper
• The role of the insulin-like growth factor system in human cancer.

  1996cites this paper
• Effect of tamoxifen on intraperitoneal N-nitroso-N-methylurea induced tumors.

  1996cites this paper
• The link between female infertility and cancer: epidemiology and possible aetiologies.

  1996cites this paper
• Tamoxifen treatment in hepatocellular carcinoma.

  1996cites this paper
• Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related: the effect of steroid hormones on insulin-like growth factor I receptor expression.

  1996cites this paper
• Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer.

  1996cites this paper
• Inhibition of endothelial adhesion and invasion by breast carcinoma cells may contribute towards the anti-metastatic effects of tamoxifen.

  1996cites this paper
• Positron Emission Tomography using [18F]fluorotamoxifen to Evaluate Therapeutic Responses in Patients with Breast Cancer: Preliminary Study

  1996cites this paper
• Type of estrogen receptor determines response to antiestrogen therapy.

  1996cites this paper
• Presence of an insulin-like growth factor I autocrine loop predicts uterine fibroid responsiveness to tamoxifen.

  1996cites this paper
• Unlabeled Milk from Cows Treated with Biosynthetic Growth Hormones: A Case of Regulatory Abdication

  1996cites this paper
• Estrogen and progesterone receptor analysis in ocular melanomas.

  1995cites this paper
• Somatuline (BIM 23014) and tamoxifen treatment of postmenopausal breast cancer patients: clinical activity and effect on insulin-like growth factor-I (IGF-I) levels.

  1995cites this paper
• Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients.

  1995cites this paper
• Insulin-like growth factors and breast cancer.

  1995cites this paper
• Transforming Growth Factor β

  1995cites this paper
• Use of pure antioestrogens to elucidate the mode of action of oestrogens.

  1995cites this paper
• Relationship between serum estradiol concentration and IGF-I, IGF-II and IGF-binding proteins in patients with premature ovarian failure on short-term estradiol therapy.

  1995cites this paper
• Timing of surgery in relation to the menstrual cycle and its influence on the survival of Japanese women with operable breast cancer

  1995cites this paper
• Potential impact on breast cancer risk of circulating insulin-like growth factor I modifications induced by oral HRT in menopause.

  1995cites this paper
• Insulin-like Growth Factors and Cancer

  1995cites this paper